Latest news

Bioservo has completed a directed issue of approximately SEK 14 million (regulatory information)

Bioservo is investigating the prerequisites for carrying out a directed share issue (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

Financial calendar

23 Feb, 2021 Year-End Report
26 Mar, 2021 Annual Report Publication
19 Apr, 2021 Annual General Meeting
04 May, 2021 2021 Quarter 1, Interim Report
12 Aug, 2021 2021 Quarter 2, Interim Report
09 Nov, 2021 2021 Quarter 3, Interim Report
17 Feb, 2022 2021 Year-End Report